Compare TEVA & GPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEVA | GPN |
|---|---|---|
| Founded | 1901 | 1967 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.2B | 17.2B |
| IPO Year | N/A | 2001 |
| Metric | TEVA | GPN |
|---|---|---|
| Price | $28.38 | $78.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 22 |
| Target Price | $27.00 | ★ $103.20 |
| AVG Volume (30 Days) | ★ 11.4M | 2.1M |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 1.27% |
| EPS Growth | N/A | ★ 34.30 |
| EPS | 0.62 | ★ 7.12 |
| Revenue | ★ $16,776,000,000.00 | $10,076,185,000.00 |
| Revenue This Year | $4.74 | N/A |
| Revenue Next Year | $0.48 | $4.44 |
| P/E Ratio | $46.12 | ★ $11.85 |
| Revenue Growth | 0.02 | ★ 22.33 |
| 52 Week Low | $12.47 | $65.93 |
| 52 Week High | $28.68 | $118.86 |
| Indicator | TEVA | GPN |
|---|---|---|
| Relative Strength Index (RSI) | 80.93 | 54.48 |
| Support Level | $24.01 | $74.72 |
| Resistance Level | $26.96 | $80.78 |
| Average True Range (ATR) | 0.68 | 1.97 |
| MACD | 0.19 | 1.07 |
| Stochastic Oscillator | 94.65 | 78.72 |
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Global Payments is a leading provider of payment processing and software solutions and focuses on serving small and midsize merchants. The company operates in 30 countries and generates about one fourth of its revenue from outside North America, primarily in Europe and Asia. In 2019, Global Payments merged with Total System Services in an all-stock deal that gave Total System Services shareholders 48% of the combined company's shares. The merger added issuer processing operations.